These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12862155)

  • 1. Experience with IUCD insertion outside of menses in Kenya.
    Kokonya DA; Sinei SK; Sekadde-Kigondu CB; Morrison CS; Kwok C; Weiner DH
    East Afr Med J; 2000 Jul; 77(7):369-73. PubMed ID: 12862155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of use of intrauterine devices among HIV-1-infected women.
    Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
    Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion.
    Sinei SK; Schulz KF; Lamptey PR; Grimes DA; Mati JK; Rosenthal SM; Rosenberg MJ; Riara G; Njage PN; Bhullar VB
    Br J Obstet Gynaecol; 1990 May; 97(5):412-9. PubMed ID: 2196934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insertion of intrauterine contraceptive device at caesarean section.
    Bhutta SZ; Butt IJ; Bano K
    J Coll Physicians Surg Pak; 2011 Sep; 21(9):527-30. PubMed ID: 21914407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genital tract infections associated with the intrauterine contraceptive device can be reduced by inserting the threads into the uterine cavity.
    Pap-Akeson M; Solheim F; Thorbert G; Akerlund M
    Br J Obstet Gynaecol; 1992 Aug; 99(8):676-9. PubMed ID: 1390474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THE EFFECT OF TWO LEVELS OF COUNSELLING ON ACCEPTANCE, UPTAKE AND EARLY OUTCOMES OF POST-PLACENTAL INTRA-UTERINE CONTRACEPTIVE DEVICE.
    Ndegwa SW; Gichuhi JW; Qureshi Z; Lubano K
    East Afr Med J; 2014 Dec; 91(12):449-56. PubMed ID: 26859013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability for the use of postpartum intrauterine contraceptive devices: Assiut experience.
    Mohamed SA; Kamel MA; Shaaban OM; Salem HT
    Med Princ Pract; 2003; 12(3):170-5. PubMed ID: 12766335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
    Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M
    Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility after contraception or abortion.
    Huggins GR; Cullins VE
    Fertil Steril; 1990 Oct; 54(4):559-73. PubMed ID: 2209874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting IUCD discontinuation in Nepal: a nested case-control study.
    Thapa S; Paudel IS; Bhattarai S; Joshi R; Thapa K
    Asia Pac J Public Health; 2015 Mar; 27(2):NP1280-7. PubMed ID: 22984134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A national study to monitor the safety of IUCD use.
    Richardson A; Paul C
    Contraception; 1993 Apr; 47(4):359-66. PubMed ID: 8508665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of removal of intrauterine contraceptive devices on colonisation of the cervix by actinomyces-like organisms.
    Mao K; Guillebaud J
    Contraception; 1984 Dec; 30(6):535-44. PubMed ID: 6529911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
    Stanback J; Grimes D
    Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged use of intrauterine contraceptive device as a risk factor for tubo-ovarian abscess.
    Charonis G; Larsson PG
    Acta Obstet Gynecol Scand; 2009; 88(6):680-4. PubMed ID: 19412803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine contraceptive device training and outcomes for healthcare providers in developed countries: A systematic review.
    Ouyang M; Peng K; Botfield JR; McGeechan K
    PLoS One; 2019; 14(7):e0219746. PubMed ID: 31306443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical versus laboratory screening for sexually transmitted infections prior to insertion of intrauterine contraception among women living with HIV/AIDS: a randomized controlled trial.
    Kakaire O; Byamugisha JK; Tumwesigye NM; Gemzell-Danielsson K
    Hum Reprod; 2015 Jul; 30(7):1573-9. PubMed ID: 25979373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial lysosomal enzyme activity in ovulatory dysfunctional uterine bleeding, IUCD users and post-partum women.
    Wang IY; Fraser IS; Barsamian SP; Manconi F; Street DJ; Cornillie FJ; Russell P
    Mol Hum Reprod; 2000 Mar; 6(3):258-63. PubMed ID: 10694274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibuprofen prevents IUCD-induced increases in menstrual blood loss.
    Mäkäräinen L; Ylikorkala O
    Br J Obstet Gynaecol; 1986 Mar; 93(3):285-8. PubMed ID: 3516203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine contraceptive device (IUCD): socio-demographic characteristics of acceptors, acceptability and effectiveness in a teaching hospital in Nigeria.
    Olatinwo AW; Anate M; Balogun OR; Alao MO
    Niger J Med; 2001; 10(1):14-7. PubMed ID: 11705047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.